Literature DB >> 11803482

Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.

Y Paranyuk1, N Claros, A Birzgalis, L C Moore, P R Brink, B Walcott.   

Abstract

PURPOSE: The fluid secretory impairment of lacrimal and salivary glands in Sjögren's syndrome (SS) is thought to be related to the extent of lymphocytic infiltration (LI) and subsequent loss of glandular tissue. In this study, we examine the correlation between the extent of tear flow reduction and the extent of LI of lacrimal glands in the NZB/W mouse, a model of SS.
METHODS: We stimulated tear production by topical application of carbachol onto the gland while fluid was collected from the lacrimal duct. The lacrimal glands were removed after fluid collection for histology.
RESULTS: Fluid secretion in response to carbachol was less in the majority of young NZB/W females compared to C57 control animals and none of the glands showed LI. Fluid secretion was also impaired in the majority of old NZB/W females, and the extent of LI was highly variable. Some of the old SW females also showed blunted fluid secretory responses and some degree of focal LI. Young SW females showed no LI and most animals exhibited normal flow responses. Analysis of paired flow and LI measurements showed no correlation between LI and flow impairment in any of the groups or in the pooled data. Carbachol-stimulated protein secretion from lacrimal gland slices in vitro were similar in young and old SW and NZB/W mice.
CONCLUSIONS: These results suggest that LI alone is not sufficient to explain the secretory dysfunction in the NZB/W mouse model of Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11803482     DOI: 10.1076/ceyr.23.3.199.5468

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  9 in total

Review 1.  The NZB/W F1 mouse model for Sjögren's syndrome: A historical perspective and lessons learned.

Authors:  Harini Bagavant; Aleksandra Michrowska; Umesh S Deshmukh
Journal:  Autoimmun Rev       Date:  2020-10-22       Impact factor: 9.754

2.  Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.

Authors:  Bruce Turpie; Takeru Yoshimura; Abha Gulati; Jose David Rios; Darlene A Dartt; Sharmila Masli
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

3.  Inflammatory stimuli accelerate Sjögren's syndrome-like disease in (NZB x NZW)F1 mice.

Authors:  Umesh S Deshmukh; Yukiko Ohyama; Harini Bagavant; Xiaoti Guo; Felicia Gaskin; Shu Man Fu
Journal:  Arthritis Rheum       Date:  2008-05

Review 4.  Dysfunction of lacrimal and salivary glands in Sjögren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model.

Authors:  Toshiharu Hayashi
Journal:  J Biomed Biotechnol       Date:  2011-06-01

5.  Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.

Authors:  Feeling Y Chen; Albert Lee; Shaokui Ge; Sara Nathan; Sarah M Knox; Nancy A McNamara
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

6.  Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.

Authors:  Shruti Singh Kakan; Maria C Edman; Alexander Yao; Curtis T Okamoto; Annie Nguyen; Brooke E Hjelm; Sarah F Hamm-Alvarez
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

7.  Identification and functional distribution of intracellular ca channels in mouse lacrimal gland acinar cells.

Authors:  W E Medina-Ortiz; E V Gregg; A M Brun-Zinkernagel; P Koulen
Journal:  Open Ophthalmol J       Date:  2007-12-04

Review 8.  Review: The Lacrimal Gland and Its Role in Dry Eye.

Authors:  Christopher D Conrady; Zachary P Joos; Bhupendra C K Patel
Journal:  J Ophthalmol       Date:  2016-03-02       Impact factor: 1.909

9.  Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.

Authors:  Yuta Ohno; Keitaro Satoh; Akiko Shitara; Takeshi Into; Masanori Kashimata
Journal:  J Physiol       Date:  2020-08-29       Impact factor: 5.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.